NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

26 hedge funds and large institutions have $1.07M invested in InVivo Therapeutics Holdings Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$33K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$591K
3
UBS Group
3
UBS Group
Switzerland
$7K
4
MAM
4
Meeder Asset Management
Ohio
$7K
5
VFA
5
Valeo Financial Advisors
Indiana
$1K

Top Sellers

1
CH
1
CVI Holdings
Delaware
$116K
2
BCM
2
Bridgeway Capital Management
Texas
$39K
3
Morgan Stanley
3
Morgan Stanley
New York
$7K
4
ICM
4
IMS Capital Management
Oregon
$45K
5
AG
5
Advisor Group
Arizona
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
26
Advantage Investment Management
Iowa
$0 40 – –
JCM
27
Jacobi Capital Management
Pennsylvania
$0 20 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
AIC
29
Ameritas Investment Company
Nebraska
$0 35 +35 New
1
2